Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Extends Three Partnerships with Pharmas

Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals announced that three of its partners have extended their strategic alliances with the company. Millennium's four-year collaboration with Pfizer, which was due to expire in December 1998, was expanded and extended for an additional two years, while a partnership with Astra will be extended for four more years. In the field of oncology, Millennium's partnership with Eli Lilly will continue an additional two years. No financial terms were disclosed.

The alliance with Pfizer, which Millennium gained through its acquisition of ChemGenics in 1997, is focused on discovery of drug leads for treating fungal infections in humans. The four-year relationship has yielded a number of targets that have advanced into drug discovery, Millennium said. As part of the two-year extension, the relationship has been expanded to create a "lead-to-target" drug discovery paradigm that expedites the identification of drug leads.

The Astra collaboration began in December 1995 and focuses on drug discovery for inflammatory respiratory diseases, including asthma, allergic rhinitis, bronchitis, emphysema, and other chronic obstructive pulmonary diseases. The four-year extension is based, in part, on Millennium's successful delivery of novel respiratory inflammation drug targets to Astra and the development of Astra's target pipeline during the alliance's first phase. Efforts of the alliance during the extension will focus on moving the targets toward drug discovery and the continued discovery and validation of new targets.

In April 1996 Millennium and Lilly entered into a strategic partnership in select areas within oncology. Lilly signed an early extension of the relationship for two more years, taking it through March 2001.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.